{
  "thread": {
    "uuid": "687a74389938b36489d86d71b1d79a96c1ba243c",
    "url": "https://finance.sina.com.cn/stock/bxjj/2025-07-31/doc-infiitzw7502858.shtml",
    "site_full": "finance.sina.com.cn",
    "site": "sina.com.cn",
    "site_section": "http://finance.sina.com.cn/money/index.shtml",
    "site_categories": [
      "tech",
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "section_title": "个人理财_个人理财规划_理财产品排行_新浪财经_新浪网",
    "site_title": null,
    "title": "来凯医药-B(02105.HK)：LAE103的新药临床试验(IND)已获得美国FDA批准_新浪财经_新浪网",
    "title_full": "来凯医药-B(02105.HK)：LAE103的新药临床试验(IND)已获得美国FDA批准_新浪财经_新浪网",
    "published": "2025-07-31T07:08:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "CN",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 236,
    "domain_rank_updated": "2025-06-03T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "687a74389938b36489d86d71b1d79a96c1ba243c",
  "url": "https://finance.sina.com.cn/stock/bxjj/2025-07-31/doc-infiitzw7502858.shtml",
  "ord_in_thread": 0,
  "author": "格隆汇APP",
  "published": "2025-07-31T07:08:00.000+03:00",
  "title": "来凯医药-B(02105.HK)：LAE103的新药临床试验(IND)已获得美国FDA批准_新浪财经_新浪网",
  "text": "格隆汇7月31日丨 来凯医药-B(02105.HK)宣布，LAE103的IND已获美国FDA批准。公司致力於为需要新型治疗方案的代谢疾病患者提供这种精准治疗。 LAE103(一种针对Act RIIB的单克隆抗体)为公司自主研发、潜在用于治疗肌少性肥胖症及其他肌肉相关疾病。\nLAE103是一款Act RIIB选择性抗体。集团正积极推动该候选药物进入临床研究阶段，旨在为肌少性肥胖症及其他肌肉相关疾病提供创新疗法。",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "positive",
  "categories": [
    "Health",
    "Science and Technology",
    "Economy, Business and Finance"
  ],
  "topics": [
    "Health->drug rehabilitation",
    "Health->medical condition",
    "Health->health treatment and procedure",
    "Science and Technology->medical research",
    "Science and Technology->biotechnology",
    "Science and Technology->biomedical science",
    "Economy, Business and Finance->products and services",
    "Economy, Business and Finance->business governance",
    "Economy, Business and Finance->healthcare industry"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": null,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2025-07-31T08:13:03.422+03:00",
  "updated": "2025-08-01T09:08:45.000+03:00"
}